Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Hepion Pharmaceuticals's total debt was $299.58K at Sep 30, 2026. For fiscal 2020 it was $0.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $299.58K | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $176.59K | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $0 | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $832.90K | – |
See a number that looks wrong?